Full lips have been a symbol of beauty for many decades, but lately the trend for a plump pout has increased significantly. Our experienced plastic surgeon offers a number of lip augmentation techniques, and one of the most popular is JUVÉDERM VOLBELLA® XC. This innovative dermal filler is FDA-approved to add volume to lips and diminish the appearance of perioral lines (wrinkles around the mouth). Therefore, whether your thinner lips are a result of genetics or the natural process of aging, JUVÉDERM VOLBELLA® XC can help you achieve the soft, sultry smile you’ve always wanted.
JUVÉDERM VOLBELLA® XC is comprised of hyaluronic acid, a hypoallergenic substance that occurs naturally in the body. It’s also the same ingredient found in JUVÉDERM®, Restylane®, and other dermal fillers. This product can be used by patients 21 years of age or older to enhance their appearance, and Dr. Charles Perry can help you determine if this or another technique offers the best option for your needs and goals.
Curious to learn more? We’re happy to answer questions! Contact Chrysalis Cosmetics to schedule your consultation with Dr. Perry.
New Injections Policy
While Dr. Perry performs many of our injectable treatments, his surgery schedule continues to grow and he wants to make injectable procedures as convenient as possible for our patients. This is why many of our injectable treatments will be performed by our extensively trained and highly skilled nurse injectors. If patients specifically request to see Dr. Perry for injectable appointments, there may be a delay of at least one month, and the treatment will require a minimum of one of these options:
- 50 units of BOTOX® Cosmetic and two syringes of a dermal filler solution
- 3 syringes of a dermal filler solution
Or
- An MD injection fee of $200 if the patient is only receiving BOTOX® Cosmetic or less than three syringes of a dermal filler solution
Please contact Chrysalis Cosmetics with any questions about our new injections policy.
Editor’s note: This blog was originally posted on January 13th, 2017.
